Upregulation of PD-L1 expression detected by immunohistochemistry has been reported in many different cancer types, e.g. melanoma (40–100%), non-small cell lung cancer (35–95%), and multiple myeloma (93%). This evidence concerns the gene CD274 and AL amyloidosis.